Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
169.49B
Market cap169.49B
Price-Earnings ratio
9.25
Price-Earnings ratio9.25
Dividend yield
3.25%
Dividend yield3.25%
Average volume
18.78M
Average volume18.78M
High today
$38.12
High today$38.12
Low today
$37.37
Low today$37.37
Open price
$37.80
Open price$37.80
Volume
12.66M
Volume12.66M
52 Week high
$64.16
52 Week high$64.16
52 Week low
$35.12
52 Week low$35.12

NVO News

Simply Wall St 4h
Novo Nordisk Stock Looks Reasonable Given Uncertain Long Term Earnings

has seen a steep share price reset in recent years, and the question now is whether the current valuation still lines up with the earnings power investors are p...

Novo Nordisk Stock Looks Reasonable Given Uncertain Long Term Earnings
Benzinga 12h
Over 88% Of Wegovy Trial Participants Achieve Normal Liver Fat Levels, Novo Reports

Novo Nordisk A/S (NYSE:NVO) on Thursday presented a post hoc analysis from a STEP UP trial sub-population, indicating that Wegovy (pooled semaglutide 7.2 and 2....

Over 88% Of Wegovy Trial Participants Achieve Normal Liver Fat Levels, Novo Reports
The Motley Fool 1d
Novo Is Open to Acquisitions. Here Are 2 Companies That Would Be Great Candidates to Buy

Novo Nordisk (NVO -1.04%) has a problem. The company generates most of its revenue from its diabetes and obesity products, but stiff competition from Eli Lilly...

Novo Is Open to Acquisitions. Here Are 2 Companies That Would Be Great Candidates to Buy

More NVO News

Benzinga 2d
Novo Nordisk Says Next-Gen Obesity Drug Reduces Food Noise, Drives Weight Loss

Novo Nordisk A/S (NYSE:NVO) on Wednesday revealed new clinical and real-world data at the 2026 European Association for the Study of Diabetes (EASD) Annual Meet...

Novo Nordisk Says Next-Gen Obesity Drug Reduces Food Noise, Drives Weight Loss
TipRanks 2d
Novo Nordisk Opens a New Front in Cardiometabolic Care With Early-Stage Anti-Inflammatory Study

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Novo Nordisk Explores New Anti-Inflammatory Pathway for Heart and Metabolic Health. Thi...

TipRanks 2d
Novo Nordisk Tests Cagrisema Switch Strategy to Strengthen Its Diabetes Franchise

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Novo Nordisk Studies Key Switch From Ozempic to Cagrisema for Type 2 Diabetes The stud...

Nasdaq 2d
Novo Nordisk Gives Uninspiring Outlook

Investors were hopeful for a better growth estimate. Missed AI’s "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they...

Novo Nordisk Gives Uninspiring Outlook
Zacks 2d
Novo Nordisk Dips More Than Broader Market: What You Should Know

Novo Nordisk (NVO Quick QuoteNVO - Free Report) closed at $38.31 in the latest trading session, marking a -1.03% move from the prior day. The stock traile...

Novo Nordisk Dips More Than Broader Market: What You Should Know
Benzinga 3d
Tirzepatide or Wegovy? Novo Nordisk Says Higher Semaglutide Dose Shows Cardiovascular Edge Over Eli Lilly's Tirzepatide

Novo Nordisk A/S (NYSE:NVO) announced on Tuesday new real-world evidence demonstrating that escalating semaglutide dosage reduces major adverse cardiovascular e...

Tirzepatide or Wegovy? Novo Nordisk Says Higher Semaglutide Dose Shows Cardiovascular Edge Over Eli Lilly's Tirzepatide
TipRanks 3d
Novo Nordisk enters into license agreement with Hengrui Pharma on HRS-1596

The company stated: “Novo Nordisk (NVO) announced that it has entered into a license agreement with Hengrui Pharma for HRS-1596, a phase 1-ready glucagon-like p...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.